5Am Venture Management, Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$360.2M
Q ending 2026-03-31
Prior quarter
$318.1M
Q ending 2025-12-31
Change
+13.2% QoQ · +36.2% YoY
Positions
20
reported holdings
Largest positions
All 20 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Erasca Inc | ERAS | Shares | $56.4M | 3.5M |
| Entrada Therapeutics Inc | TRDA | Shares | $51.2M | 4.1M |
| Tyra Biosciences Inc | TYRA | Shares | $39.4M | 1.0M |
| Camp4 Therapeutics Corp | CAMP | Shares | $25.9M | 5.9M |
| Centessa Pharmaceuticals Plc | 260 | Shares | $23.1M | 581K |
| Pharvaris N V | Shares | $22.5M | 798K | |
| Maplight Therapeutics Inc | MPLT | Shares | $19.3M | 950K |
| Tectonic Therapeutic Inc | TECX | Shares | $18.8M | 607K |
| Celldex Therapeutics Inc New | CLDX | Shares | $15.8M | 497K |
| Artiva Biotherapeutics Inc | ARTV | Shares | $15.2M | 2.4M |
| Eyepoint Inc | EYPT | Shares | $13.5M | 1.1M |
| Surrozen Inc | SRZN | Shares | $11.3M | 388K |
| Zentalis Pharmaceuticals Inc | ZNTL | Shares | $9.2M | 3.9M |
| Gh Research Plc | Shares | $8.1M | 573K | |
| Protara Therapeutics Inc | TARA | Shares | $7.1M | 1.4M |
| Biohaven Ltd | Shares | $6.3M | 739K | |
| Alx Oncology Hldgs Inc | ALXO | Shares | $6.1M | 3.1M |
| Skye Bioscience Inc | SKYE | Shares | $6.0M | 9.7M |
| Rallybio Corp | RLYB | Shares | $2.6M | 292K |
| Silence Therapeutics Plc | SLN | Shares | $2.5M | 476K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.